Similar results were seen for an a priori defined cut point43 for P-tau/Aβ42 (>0.022) with high specificity (61 of 66 ADNC none-low, 92%) and high sensitivity (25 of 28 ADNC intermediate-high, 89%) for AD neuropathology. Here, MAPT is linked to Alzheimer disease.